Oric Pharmaceuticals Rating Update
On 26 October 2026, Pro News published a brief notice titled “Oric Pharmaceuticals Inc receives Investment Bank Analyst Rating Update.” The article, authored by Garrett Cook, was first released at 04:09 am and subsequently updated at 04:15 am the same morning. The notice confirms that an investment‑bank analyst has issued a rating update for Oric Pharmaceuticals Inc, but it does not disclose the nature of the rating change, the specific rating level, or any quantitative metrics associated with the update. No additional commentary, target price, or forward‑looking statements were provided. The announcement is limited to the fact of the rating update and the publication timestamps, with no further details on the analyst’s assessment or its implications for the company’s share price or valuation.